Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

neratinib MeSH Supplementary Concept Data 2026


MeSH Supplementary
neratinib
Unique ID
C487932
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C487932
Entry Term(s)
HKI 272
HKI-272
HKI272
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
Nerlynx
neratinib maleate
Pharm Action
Tyrosine Kinase Inhibitors
Registry Numbers
JJH94R3PWB
0
Heading Mapped to
*Quinolines
Frequency
260
Note
an orally active, irreversible inhibitor of the HER-2 tyrosine kinase
Source
Cancer Res 2004 Jun 1;64(11):3958-65
Date Introduced
2004/07/22
Last Updated
2023/08/04
neratinib Preferred
HKI 272 Narrower
Nerlynx Related
neratinib maleate Related
page delivered in 0.003s